We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Spinnaker Opportunities Plc | LSE:SOP | London | Ordinary Share | GB00BYQCS703 | ORD 2.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.65 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
16/2/2021 13:59 | Looks like we've cleared the 20p marker. f | fillipe | |
16/2/2021 10:07 | Lowest ASKL showcasing is now 17p. f | fillipe | |
16/2/2021 08:47 | Well done lads. Got rid of mine above the 15p level from a 4p average. | shortcpx | |
16/2/2021 08:15 | Why has vela notified such a small Holding ! | tenniselbow | |
16/2/2021 07:59 | Several platforms still have this under the old ticker SOP so just buy using that. | trying2getrichquick | |
16/2/2021 07:37 | Kanabo thread KNB | currypasty | |
16/2/2021 07:36 | How can you buy... knb doesn't come up as stock | easwarareddy | |
16/2/2021 07:13 | Stand by your beds! Almost ready to go.... | tinker10 | |
15/2/2021 21:20 | Details of the subscriptionVela has entered into a conditional placing letter pursuant to which it has agreed to invest GBP150,000 in Kanabo Group plc, funded from the Company's existing cash resources. Vela has subscribed for 2,307,692 new ordinary shares at a price of 6.5 pence per ordinary share, valuing the enlarged Kanabo Group plc at GBP23.4 million on admission. Following admission to trading on the main market of the London Stock Exchange, Vela will hold approximately 0.6 per cent. of the issued share capital of Kanabo Group plc. | oapknob1 | |
15/2/2021 21:19 | Issue price 6.5p What MM price/spike it to is anyone's guess | oapknob1 | |
15/2/2021 16:56 | HL said they hope to have it ready as it's SOP name on HL at the moment. It's planning on lifting the suspension tomorrow at 8am | richardp19 | |
15/2/2021 15:05 | Okay great. Ive just spoke to Hl and they are unsure wether they will be holding this. So actually unSure if i will be able to purchase tomorrow | lc123 | |
15/2/2021 15:03 | yes, its in the 195 page prospectus KNB new thread for tomorrow | currypasty | |
15/2/2021 15:01 | Thanks. What price do you think we will get on the market tomorrow. And what is expected. | lc123 | |
15/2/2021 14:11 | Kanabo Group - KBN I think. | the drewster | |
15/2/2021 14:04 | Hi, how do i purchase this stock before it enters lse tomorrow. | lc123 | |
15/2/2021 12:11 | Im with HL as well, no idea if they will be up to speed.. hope so!!!!! | currypasty | |
15/2/2021 12:09 | Question please.....Can any fellow HL client confirm whether KNB will be a tradeable entity on the HL platform at 8am tomorrow. Thank you. | flashheart | |
15/2/2021 10:09 | (Alliance News) - An Israeli-founded medical cannabis firm has hailed a "pivotal moment" for the sector as it edges nearer to its float on the London stock exchange. Kanabo Research Ltd, which makes vaporisers using a cannabis component, was among a raft of firms competing to become the first cannabis-related business to list in London after city regulators gave a green light last month. Last week, MGC Pharmaceuticals Ltd and David Beckham-backed Cellular Goods PLC opened for trading in London amid burgeoning interest from potential investors. Kanabo is to make its stock market debut on Tuesday in a listing expected to value the company at GBP23.2 million. The business has raised GBP6 million to fund its growth strategy following the listing. Avihu Tamir, chief executive, told the PA news agency that both retail and institutional investors were clamouring to enter the rapidly growing medical cannabis sector. "We could have secured at least GBP11 million in investment but we had to stop sooner," he said. "It's a really interesting time to be involved in the sector and investors know this. It's not just retail investors รข€“ we were surprised by the number of institutions who have already invested in Canada and are keen to join us and the others listing in London. "It's a pivotal moment for us and others in medical cannabis because that FCA (Financial Conduct Authority) decision gave us another level of accountability." Tamir said the funds will go towards further clinical trials and expanding the wellness operations of the business. The vaporiser delivers a precise one milligramme dose to users with every inhalation, he said. Simon Erridge, co-founder and trustee of medical cannabis charity Sapphire Medical Foundation, said: "The disconnect between patient demand and the access of medical cannabis is prolonging the suffering of potentially millions of patients. "News that Kanabo has developed a medical cannabis vaporising solution that delivers a quality product with a precise measured dose and expects to IPO on the LSE clearly signifies a momentum change that will improve accessibility for patients in the UK." | johnyee 7 | |
12/2/2021 13:59 | Next week is sure to see a lot of FOMO, following the rise in such as MXC. f | fillipe | |
12/2/2021 09:20 | fresh warrants implies in my mind they replace old ones... or they would be described as new warrants ? | currypasty |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions